This study is completed in the United States, in Canada, and in Israel. It is testing Manualized MDMA-Assisted Psychotherapy for PTSD.
PTSDBehavioralOver 18 Years
The public registry lists this study as not currently recruiting. This page remains available for information. Check the official record for the latest status and explore other recruiting studies.
Then choose your country and confirm availability with each study site.
In plain English
Key information made simple
What is this study testing?
This study is testing whether a digital tool or app may be useful for adults experiencing ptsd.
What would participation involve?
Participants may use a digital tool or app, attend study visits with the research team. The protocol may also involve randomization, placebo, or a comparison group. The registry lists locations in Canada, in Israel, and in the United States.
Who is it mainly for?
This study appears to be mainly for adults with ptsd.
What should you check before joining?
Ask about whether participation can be remote and what device access is needed, whether there is placebo, randomization, or a comparison group, how many visits or travel steps are needed, the exact eligibility criteria.
Your next step
Check the study details
Check the official source, then confirm these points with the research team.
Where are visits, can any be remote, and how much time is needed?
Costs and support
What costs, reimbursement or compensation apply?
Before joining
Questions to ask before joining
What are the exact eligibility criteria, and what could exclude someone?
How many visits, assessments, or follow-ups are expected, and over what period?
What risks, side effects, practical burdens, or alternatives should be understood first?
Who should be contacted to confirm locations, timing, compensation, and next steps?
Study clarity
Things to check before joining
Study start dateStarted: November 21, 2018
Recruitment status
Completed
Enrollment listed in the registry
100
Sponsor
Resilient Pharmaceuticals
Sponsor type
Unknown or unclear
Study type
Behavioral
Intervention type
Psychotherapy / behavioral intervention, Medication / drug
Study phase
Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.
Locations
United States, Canada, Israel
Age range
Over 18 Years
Official registry ID
NCT03537014
Official title
A Randomized, Double-Blind, Placebo-Controlled, Multi-Site Phase 3 Study of the Efficacy and Safety of Manualized MDMA-Assisted Psychotherapy for the Treatment of Severe Posttraumatic Stress Disorder
Ask HopeStage to help me review this study
This record does not confirm open recruitment. We can help you understand it and explore other studies.
Study ID: NCT03537014. We help you review the study, but cannot decide medical eligibility.
Check recruitment and locations
Recruitment checked against the registry by HopeStage on . Registry information can change. Always confirm availability with the research team.
The overall study status can differ from each site's status. Open a country to see its locations and their registry status.
Canada · 2 sites
Providence Health Center
Vancouver, British Columbia
Site status: Not listed — confirm with the team
Dr. Simon Amar, Inc.
Montreal, Quebec
Site status: Not listed — confirm with the team
Israel · 2 sites
Assaf Harofeh Research Fund
Be’er Ya‘aqov
Site status: Not listed — confirm with the team
Sheba Fund for Health Services and Research
Tel Litwinsky
Site status: Not listed — confirm with the team
United States · 11 sites
New School Research LLT
North Hollywood, California
Site status: Not listed — confirm with the team
San Francisco Insight and Integration Center
San Francisco, California
Site status: Not listed — confirm with the team
University of California San Francisco
San Francisco, California
Site status: Not listed — confirm with the team
Aguazul-Blue Water Inc.
Boulder, Colorado
Site status: Not listed — confirm with the team
Wholeness Center
Fort Collins, Colorado
Site status: Not listed — confirm with the team
Ray Worthy Psychiatry LLC
New Orleans, Louisiana
Site status: Not listed — confirm with the team
Trauma Research Foundation
Boston, Massachusetts
Site status: Not listed — confirm with the team
New York University
New York, New York
Site status: Not listed — confirm with the team
New York Private Practice
New York, New York
Site status: Not listed — confirm with the team
Zen Therapeutic Solutions, LLC
Mt. Pleasant, South Carolina
Site status: Not listed — confirm with the team
University of Wisconsin at Madison
Madison, Wisconsin
Site status: Not listed — confirm with the team
In practice
For you
Participation may contribute to research. Personal benefit is not guaranteed.
Ask the research team to explain the activities, time commitment, and follow-up involved.
Study sites are listed. Confirm the relevant site and any travel before making plans.
Important
Not medical advice
Information from public sources.
Are you the study sponsor? Contact us to update this page: hi@hopestage.com
FAQ
Questions about this study
What is this study trying to understand?
Based on the public registry summary, this study is trying to understand: The goal of this clinical trial is to learn if MDMA-assisted therapy is safe and effective in people with at least severe PTSD. The main question it aims to answer is: Do three sessions of MDMA-assisted therapy reduce PTSD symptoms? Researchers will compare three sessions of. The study team can confirm the exact objective and what it means for you.
What is a behavioral study?
This appears to be a behavioral / psychological / psychosocial study involving Therapy, midomafetamine HCl, Placebo. Phase 3 studies are usually larger and aim to confirm effectiveness and safety in a broader group.
Who might this study be for?
This study may concern people with ptsd; age range: Over 18 Years. The criteria appear fairly specific, but you should not assume you are eligible. The study team must confirm diagnosis, age, exclusions, available locations, and next steps.
What would I likely need to do?
You may take part in sessions or exercises related to habits, thoughts, emotions, or behaviors. The listed study locations suggest that at least part of participation may involve a physical site. Ask whether some steps can be done remotely.
Could this study affect my mood, habits, motivation, or stress?
Behavioral studies can involve habits, emotions, motivation, stress, sleep, or ways of thinking. Ask whether the intervention could affect your mood or stress, and who to contact if you feel worse. For any mental health study, also ask who to contact if you feel worse, whether participation may affect current treatment, whether you can stop, and who confirms eligibility.
Will I need to travel or attend in-person visits?
The listed study locations suggest that at least part of participation may involve a physical site. Ask which sites are open, how many visits are expected, whether any steps can be done remotely, and whether travel costs or compensation are listed.
Who is behind this study?
This study is sponsored by Resilient Pharmaceuticals, which appears to be unknown or unclear. If available, it can be useful to check the sponsor website, collaborators, investigator affiliation, and the official registry before deciding. HopeStage does not judge the quality of a sponsor or researcher, but helps you identify what to verify.
Can I still join this study?
The public registry lists this study as not currently recruiting. This page remains available for information. Check the official record for the latest status and explore other recruiting studies.
Explore other studies
Want to find a study that may fit you better?
Answer a few simple questions to explore HopeStage studies by condition, country, and situation.
